Melvin Mangulabnan
Internal Medicine · West Seneca, NYNPI 1871540484
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AstraZeneca at 29.7% of the total. Reporting peaked in 2019 at $1,232 and has fallen 72.0% since, to $345 in 2022.
Across 123 payments — averaging $23.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$843
- Novo Nordisk$488
- Boehringer Ingelheim$383
- Amgen$216
- Novartis$201
- Lilly USA, LLC$155
- plus $549 from 9 others
What the payments were for
- Food & beverage$2,836100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 20 | $843 |
| Novo Nordisk | 26 | $488 |
| Boehringer Ingelheim | 15 | $383 |
| Amgen | 7 | $216 |
| Novartis | 12 | $201 |
| Lilly USA, LLC | 9 | $155 |
| Johnson & Johnson | 9 | $151 |
| Kowa Pharmaceuticals America, Inc. | 6 | $92 |
| Amarin Pharma, Inc. | 5 | $82 |
| Merck | 5 | $71 |
| Pfizer | 3 | $52 |
| Astellas Pharma US Inc | 2 | $36 |
| AbbVie | 2 | $31 |
| Genentech USA, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,836 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $193 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in West Seneca
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.